Membrane-type I matrix metalloproteinase (MTI-MMP) is a presumed activ
ator of MMP2, which is one of the major proteinases in tumor cell inva
sion, in this study, we determined the clinico-pathologic significance
of MTI-MMP expression in 68 human gastric carcinomas. The tumor-norma
l ratio (TIN ratio) of MTI-MMP expression was determined by reverse tr
anscription-polymerase chain reaction analysis. To visualize the local
ization of MTI-MMP, an immunohistochemical study was performed. In add
ition, a gelatin zymography was done to examine the activation ratio o
f MMP2, and a correlation between MTI-MMP expression and activation of
MMP2 was studied. The expression of MTI-MMP mRNA was higher in tumor
tissue than in corresponding normal tissue in most cases. The mean val
ue of the T/N ratio was 4.8. Twenty cases with T/N greater than or equ
al to 4.8 showed significantly deeper invasion and higher frequency of
lymph node metastasis than 48 cases with TIN < 4.8. MTI-MMP expressio
n was an independent factor influencing both tumor invasion of the gas
tric wall and lymph node metastasis. Although MTI-MMP expression was n
ot an independent prognostic factor, the patients with T/N greater tha
n or equal to 4.8 showed a significantly worse prognosis than those wi
th T/N < 4.8. An immunohistochemical study demonstrated that MTI-MMP e
xpression was mainly recognized in the tumor cells, There was a signif
icant correlation between MTI-MMP expression and activation of MMP2. O
ur findings suggest that: 1) the expression of MTI-MMP may influence p
rognosis via tumor invasion of the gastric wall and lymph node metasta
sis, and 2) MTI-MMP activation of MMP2. may be clinically relevant in
gastric carcinoma tumors. (C) 1997 Wiley-Liss, Inc.